Causes of a Low Measles Seroprevalence among Young Healthcare Workers in Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Sporadic measles outbreaks have continued to occur in Korea, mainly in adults in their 20s and 30s, most notably in 2014 and 2019. We here evaluated the possible causes of a low seroprevalance of measles by testing young healthcare workers (HCWs). Materials and Methods: This study was conducted in a 2,743-bed tertiary-care hospital in Seoul between 2020 and 2021. We performed a measles antibody test (chemiluminescence immunoassay), measured the IgM/IgG index ratio, and conducted an avidity test at 1-month after Measles-Mumps-Rubella (MMR) vaccination in HCWs who had been seronegative for measles. Measles vaccination histories were obtained from the national vaccine registry. Results: Of the 3,173 HCWs newly employed in our hospital during the study period, 54 with a negative measles IgG at commencement were enrolled. Thirty six (67%) of these subjects were female, and the median age was 25 years (interquartile range [IQR]: 24 - 27). Fourty nine (91%) showed seroconversion at 1 month after the first vaccination. Of these individuals, 38 received both measles IgM and IgG test, and all had an IgM/IgG index <1. Of the 49 seroconverters, all HCWs showed a high avidity index. According to the national immunization registry, 45 (83%) received at least 2 doses of an MMR vaccination. Conclusion: Secondary vaccine failure may underlie vaccine failure in young Korean adults. HCWs born after 1985 with a negative measles antibody may need only a single dose booster vaccination rather than a 2-dose vaccination regimen.
Abstract
Background: Sporadic measles outbreaks have continued to occur in Korea, mainly in adults in their 20s and 30s, most notably in 2014 and 2019. We here evaluated the possible causes of a low seroprevalance of measles by testing young healthcare workers (HCWs). Materials and Methods: This study was conducted in a 2,743-bed tertiary-care hospital in Seoul between 2020 and 2021. We performed a measles antibody test (chemiluminescence immunoassay), measured the IgM/IgG index ratio, and conducted an avidity test at 1-month after Measles-Mumps-Rubella (MMR) vaccination in HCWs who had been seronegative for measles. Measles vaccination histories were obtained from the national vaccine registry. Results: Of the 3,173 HCWs newly employed in our hospital during the study period, 54 with a negative measles IgG at commencement were enrolled. Thirty six (67%) of these subjects were female, and the median age was 25 years (interquartile range [IQR]: 24 - 27). Fourty nine (91%) showed seroconversion at 1 month after the first vaccination. Of these individuals, 38 received both measles IgM and IgG test, and all had an IgM/IgG index <1. Of the 49 seroconverters, all HCWs showed a high avidity index. According to the national immunization registry, 45 (83%) received at least 2 doses of an MMR vaccination. Conclusion: Secondary vaccine failure may underlie vaccine failure in young Korean adults. HCWs born after 1985 with a negative measles antibody may need only a single dose booster vaccination rather than a 2-dose vaccination regimen.
참고문헌 (20)
- In H, "Measles and Rubella elimination and current status in Korea", Pub Health Wkly Rep, 11, pp.1478~1482 (2018)
- 최영준, "An Outbreak of Measles in a University in Korea, 2014", Journal of Korean Medical Science, 32(11), pp.1876~1878 (2017), 대한의학회
- Choi S, "Analysis of the occurrence of measles in Korea, 2019", Pub Health Wkly Rep, 13, pp.2453~2458 (2020)
- Kang Jin-Han, "Review of Measles in Korea: Quarantine and Elimination", Infection and Chemotherapy, 52(1), pp.113~122 (2020), 대한감염학회[DOI]
- 정지원, "Seroprevalence of Measles in Healthcare Workers in South Korea", Infection and Chemotherapy, 51(1), pp.58~61 (2019), 대한감염학회[DOI]
- 장현하, "Preliminary Report of Seroprevalence of Anti-Measles Immunoglobulin G among Healthcare Workers of 6 Teaching Hospitals of Daegu, Korea in 2019", Infection and Chemotherapy, 51(1), pp.54~57 (2019), 대한감염학회[DOI]
- Han SB, "Measles seroprevalence among healthcare workers in South Korea during the post-elimination period", Hum Vaccin Immunother, 17, pp.2517~2521 (2021)
- Kwak Yee Gyung, "Comparison of the Seroprevalence of Measles Antibodies among Healthcare Workers in Two Korean Hospitals in 2019", Infection and Chemotherapy, 52(1), pp.93~97 (2020), 대한감염학회[DOI]
- Seok Hyeri, "Report of the Korean Society of Infectious Diseases Roundtable Discussion on Responses to the Measles Outbreaks in Korea in 2019", Infection and Chemotherapy, 53(3), pp.405~420 (2021), 대한감염학회[DOI]
- Erdman DD, "Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection", J Med Virol, 41, pp.44~48 (1993)
- Markowitz LE, "Duration of live measles vaccine-induced immunity", Pediatr Infect Dis J, 9, pp.101~110 (1990)
- Hickman CJ, "Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals", J Infect Dis, 204(Suppl 1), pp.S549~58 (2011)
- Davidkin I, "Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort : a 20-year follow-up", J Infect Dis, 197, pp.950~956 (2008)
- Kang HJ, "An increasing, potentially measles-susceptible population over time after vaccination in Korea", Vaccine, 35, pp.4126~4132 (2017)
- Kim ES, "Seroprevalence of measles among children affected by national measles elimination program in Korea, 2010", Vaccine, 30, pp.3355~3359 (2012)
- Kim CJ, "Risk of absence of measles antibody in healthcare personnel and efficacy of booster vaccination", Vaccines(Basel), 9, pp.501~ (2021)
- Seok H, "Immunogenicity after outbreak response immunization activities among young healthcare workers with secondary vaccine failure during the measles epidemic in Korea, 2019", BMC Infect Dis, 22, pp.530~ (2022)
- "Guideline for response to the measles" (2019)[URL]
- Fiebelkorn AP, "Measles virus neutralizing antibody response, cell-mediated immunity, and immunoglobulin G antibody avidity before and after receipt of a third dose of measles, mumps, and rubella vaccine in young adults", J Infect Dis, 213, pp.1115~1123 (2016)
- Correa VA, "Modified ELISA for antibody avidity evaluation : The need for standardization", Biomed J, 44, pp.433~438 (2021)